Analyst Projections and Ratings for bluebird bio NASDAQ BLUE
Analyst projections for bluebird bio (NASDAQ: BLUE) are varied, with a range of viewpoints from bullish to bearish. In the ...
Tag: BLUE
Financial Analyst Maintains Reduce Rating on bluebird bio and Downgrades Home Depot
On March 5, 2024, Morten Herholdt, an analyst at HSBC, decided to maintain his Reduce rating on bluebird bio (NASDAQ:BLUE) ...
Popular News
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
-
NextGen Healthcare Charts Course for Behavioral Health Transformation
-
Regulatory Shift Sparks Potential Breakthrough for DeFi Technologies
